{
  "id": 1469,
  "text": "31), respectively), and the incidence of thrombocytopenia with CCRT (cisplatin $^ +$ gemcitabine) was higher $\\mathrm { { O R } = 4 .4 4 }$ $[ 9 5 \\% \\mathrm { C I } = 1 .6 3 \\ – 1 2 .0 7 )$ ).In terms of gastrointestinal toxicity, the incidence of diarrhea and vomiting with CCRT (cisplatin $^ +$ gemcitabine) was higher than CCRT (cisplatin) $\\mathrm { \\Delta O R } = 3 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 31), respectively), and the incidence of thrombocytopenia with CCRT (cisplatin $^ +$ gemcitabine) was higher $\\mathrm { { O R } = 4 .4 4 }$ $[ 9 5 \\% \\mathrm { C I } = 1 .6 3 \\ – 1 2 .0 7 )$ ).In terms of gastrointestinal toxicity, the incidence of diarrhea and vomiting with CCRT (cisplatin $^ +$ gemcitabine) was higher than CCRT (cisplatin) $\\mathrm { \\Delta O R } = 3 .\n\n<question>: ",
  "ChatGPT_response_0": "联合使用顺铂和吉西他滨的化疗在胰腺癌患者中引起的血小板减少发生率更高。研究表明，在顺铂和吉西他滨联合化疗的方案中，血小板减少的风险较单一用药顺铂治疗更高。这可能会增加患者在治疗过程中的出血风险，需要密切监测血小板计数并采取相应措施。在临床实践中，医生通常会综合考虑患者的整体状况和预期疗效来选择最合适的治疗方案，以确保患者获得最佳的治疗效果和生活质量。",
  "query": "对于胰腺癌患者，与单一用药顺铂治疗相比，联合使用顺铂和吉西他滨的化疗引起的血小板减少发生率更高吗？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于胰腺癌患者，与单一用药顺铂治疗相比，联合使用顺铂和吉西他滨的化疗引起的血小板减少发生率更高吗？\n\n<reference text>: 31), respectively), and the incidence of thrombocytopenia with CCRT (cisplatin $^ +$ gemcitabine) was higher $\\mathrm { { O R } = 4 .4 4 }$ $[ 9 5 \\% \\mathrm { C I } = 1 .6 3 \\ – 1 2 .0 7 )$ ).In terms of gastrointestinal toxicity, the incidence of diarrhea and vomiting with CCRT (cisplatin $^ +$ gemcitabine) was higher than CCRT (cisplatin) $\\mathrm { \\Delta O R } = 3 .\n\n<reply>: ",
  "response": "联合使用顺铂和吉西他滨的化疗在胰腺癌患者中引起的血小板减少发生率更高。研究表明，在顺铂和吉西他滨联合化疗的方案中，血小板减少的风险较单一用药顺铂治疗更高。这可能会增加患者在治疗过程中的出血风险，需要密切监测血小板计数并采取相应措施。在临床实践中，医生通常会综合考虑患者的整体状况和预期疗效来选择最合适的治疗方案，以确保患者获得最佳的治疗效果和生活质量。"
}